In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 37, Issue 4, 2009, Pages 156-162

  Johnson, Jennifer L H ^a   Dolezal, Melissa C ^a   Kerschen, Arthur ^a   Matsunaga, Terry O ^a   Unger, Evan C ^a  

^a NuvOx Pharma LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVERAGE PARTICLE SIZE; DODECAFLUOROPENTANE; IN-VITRO; IN-VIVO; MEDICAL CONDITIONS; OXYGEN CARRIER; OXYGEN DELIVERY; OXYGEN EXCHANGE; OXYGEN UPTAKE; PERFLUORODECALIN; ROOM TEMPERATURE; VOLUME EXPANSION;

EMULSIFICATION; WATER TREATMENT;

OXYGEN;

BROMINE DERIVATIVE; OXYGEN; PERFLUOROCTYLBROMIDE; PERFLUORODECALIN; PERFLUOROPENTANE; UNCLASSIFIED DRUG; WATER;

ABSORPTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EMULSION; IN VITRO STUDY; IN VIVO STUDY; OXYGEN CONSUMPTION; PARTICLE SIZE; ROOM TEMPERATURE;

ABSORPTION; ANOXIA; BLOOD SUBSTITUTES; EMULSIONS; FLUOROCARBONS; OXYGEN; PARTICLE SIZE;

EID: 68849091794     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.1080/10731190903043192     Document Type: Article

References (30)

1. Dias, A.M.A., Freire, M., Coutinho, J.A.P., Marrucho, I.M. (2004). Solubility of oxygen in liquid perfluorocarbons. Fluid Phase Equilibria. 222-223, 325-330.
2. Cheung, A.T., To, P.L., Chan, D.M., Ramanujam, S., Barbosa, M.A., Chen, P.C., Driessen, B., Jahr, J.S., Gunther, R.A. (2007). Comparison of treatment modalities for hemorrhagic shock. Artif. Cells Blood Substit Immobil. Biotechnol. 35(2):173-190.
3. Schoenberg, M.H., Beger, H.G. (1993). Reperfusion injury after intestinal ischemia. Crit. Care Med. 21(9):1376-1386.
4. Grace, P.A. (1994). Ischemia-reperfusion injury. Brit. J. Surg. 81:637-647.
5. Koch, C.J., Oprysko, P.R., Shuman, A.L., Jenkins, W.T., Brandt, G., Evans, S.M. (2002). Radiosensitization of hypoxic tumor cells by dodecafluoropentane: a gas-phase perfluorochemical emulsion. Cancer Research. 62: 3626-3629.
6. Lundgren, C., Bergoe, G., Olszowka, A., Tyssebotn, I. (2005). Tissue nitrogen elimination in oxygen-breathing pigs is enhanced by fluorocarbon-derived intravascular micro-bubbles. UHM 32(4):215-226.
7. Van Liew, H.D., Burkard, M.E. (1996). Relationship of oxygen content to PO2 for stabilized bubbles in the circulation: theory. J. Appl. Physiol. 81(1):500-508.
8. Fagan, S.C., Morgenstern, L.B., Petitta, A., Ward, R.E., Tilley, B.C., Marler, J.R., Levine, S.R., Broderick, J.P., Kwiatkowski, T.G., Frankel, M., Brott, T.G., Walker, M.D. (1998). The NINDS rt-PA Stroke Study Group. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology. 50:883-890.
9. Levi., C.R. (2004). Tissue plasminogen activator (tPA) in acute ischaemic stroke: time for collegiate communication and consensus. The Medical Journal of Australia. 180(12):634-636.
10. Robbin, M.L., Eisenfeld, A.J. (1998). Perflenapent emulsion; a US contrast agent for diagnostic radiology-multicenter, double-blind comparison with a placebo. Radiology. 207:717-722.
11. Lundgren, C., Bergoe, G., Olszowka, A., Tyssebotn, I. (2006). Intravascular fluorocarbon-stabilized microbubbles protect against fatal anemia in rats. Artificial Cells, Blood Substitutes, and Biotechnology. 34(5):473-468.
12. 2 transport in dogs. J. Appl. Physiol. 79(5):1777-1786.
13. Lowe, K.C. (2001). Fluorinated blood substitutes and oxygen carriers. Journal of Fluorine Chemistry. 109:59-65.
14. Leese, P.T., Noveck, R.J., Shorr, J.S., Woods, CM., Flaim, K.E., Keipert, P.E. (2000). Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers. Anesth. Analg. 91:804-811.
15. Wahr, J.A., Trouwborst, A., Spence, R.K., Henny, C.P., Ceraianu, A.C., Graziano, G.P., Tremper, K.K., Flaim, K.E., Faithfull, N.S., Clymer, J.J. (1996). A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients. Anesth. Analg. 82:103-107.
16. Kiral, R.M., Nicora, R., Evitts, D.P. (2002). Comparison of oxygen carrying capacity of a new perfluorocarbon (pfc) blood substitute in rats breathing room air or 100% oxygen. Presented at: APS Intersociety Meeting, San Diego, CA.
17. Dias, A.M.A., Goncalves, C.M.B., Legido, J.L., Coutinho, J.A.P., Marrucho, I.M. (2005). Solubility of oxygen in substituted perfluorocarbons. Fluid Phase Equilibria. 238:7-12.
18. Krafft, M.P. (2001). Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Advanced Drug Delivery Reviews 47:209-228.
19. Flaim, S.F. (1994). Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. Art. Cells, Blood Subst., Immob. Biotech. 22:1043-1054.
20. Tremper, K.K. (1999). Perfluorochemical blood substitutes. Anesthesiology. 91:1185-1187.
21. Burkard, M.E., Van Liew, H.D. (1994). Oxygen transport to tissues by persistent bubbles: theory and simulations. J. Appl. Physiol. 77:2874-2878.
22. Takanori, Y., Schmid-Schonbein, G.W., Cotter, B., De-Maria, A.N. (1999). Flow dynamics of QW7437, a new dodecafluoropentane ultrasound contrast agent, in the microcirculation. J. Amer. Coll. Cardiology 34(2):578-586.
23. Correas, J.M., Meuter, A.R., Singlas, E., Kessler, D.R., Worah, D., Quay, S.C. (2001). Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound in Med. Biol. 27(4):565-570.
24. Riess, J.G. (2005). Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Aritficial Cells, Blood Substitutes, and Biotechnology 33:47-63.
25. Van Liew, H.D., Burkard, M.E. (1995). Bubbles in circulating blood: stabilization and simulations of cyclic changes of size and content. J. Appl. Physiol. 79 (4):1379-1385.
26. Van Liew, H.D., Raychaudhuri, S. (1997). Stabilized bubbles in the body: pressure-radius relationships and the limits to stabilization. J. Appl. Physiol. 82:2045-2053.
27. Van Liew, H.D., Burkard, M.E. (1995). Behavior of bubbles of slowly permeating gas used for ultrasonic imaging contrast. Investigative Radiology 30(5):315-321.
28. Kerschen, A. (2007). Universal COM Logger software (communications port data logger), Tucson, AZ.
29. Lowe, K.C. (1991). Perfluorochemicals in medicine. Chemistry and Industry 3(83):1-6.
30. Toft, K.G., Hustvedt, S.O., Hals, P.A., Oulie, I., Uran, S., Landmark, K, Normann, P.T., Skotland, T. (2006). Disposition of perfluorobutane in rats after intravenous injection of Sonazoid. Ultrasound in Med. Biol. 32(1):107-114.